Novel pyrazoloisoquinoline derivatives as kinase inhibitors are disclosed which are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
揭示了作为激酶
抑制剂的新型
吡唑异喹啉衍
生物,适用于生产用于预防和治疗涉及NIK增强活性的疾病的药物。